Annual CAPEX
$11.97 M
-$25.22 M-67.81%
31 December 2023
Summary:
CRISPR Therapeutics AG annual capital expenditures is currently $11.97 million, with the most recent change of -$25.22 million (-67.81%) on 31 December 2023. During the last 3 years, it has fallen by -$6.39 million (-34.80%). CRSP annual CAPEX is now -85.35% below its all-time high of $81.70 million, reached on 31 December 2021.CRSP CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
N/A
30 September 2024
Summary:
CRISPR Therapeutics AG quarterly capital expenditures is not available.CRSP Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
N/A
30 September 2024
Summary:
CRISPR Therapeutics AG TTM capital expenditures is not available.CRSP TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRSP CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -67.8% | - | - |
| 3 y3 years | -34.8% | - | - |
| 5 y5 years | +331.7% | - | - |
CRSP CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -85.3% | at low | ||||
| 5 y | 5 years | -85.3% | +331.7% | ||||
| alltime | all time | -85.3% | +937.3% |
CRISPR Therapeutics AG CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $11.97 M(-67.8%) | $738.00 K(-76.3%) | $11.97 M(-31.3%) |
| Sept 2023 | - | $3.12 M(-38.3%) | $17.42 M(-14.3%) |
| June 2023 | - | $5.05 M(+65.3%) | $20.32 M(-18.4%) |
| Mar 2023 | - | $3.06 M(-50.6%) | $24.90 M(-33.1%) |
| Dec 2022 | $37.19 M(-54.5%) | $6.19 M(+2.9%) | $37.19 M(-7.4%) |
| Sept 2022 | - | $6.02 M(-37.5%) | $40.18 M(-43.6%) |
| June 2022 | - | $9.63 M(-37.3%) | $71.21 M(-20.9%) |
| Mar 2022 | - | $15.35 M(+67.2%) | $90.03 M(+10.2%) |
| Dec 2021 | $81.70 M(+345.1%) | $9.18 M(-75.2%) | $81.70 M(+3.7%) |
| Sept 2021 | - | $37.05 M(+30.2%) | $78.76 M(+66.7%) |
| June 2021 | - | $28.45 M(+305.0%) | $47.23 M(+111.0%) |
| Mar 2021 | - | $7.02 M(+12.6%) | $22.39 M(+22.0%) |
| Dec 2020 | $18.36 M(+174.7%) | $6.24 M(+13.0%) | $18.36 M(+40.4%) |
| Sept 2020 | - | $5.52 M(+53.2%) | $13.07 M(+30.6%) |
| June 2020 | - | $3.60 M(+20.5%) | $10.01 M(+16.7%) |
| Mar 2020 | - | $2.99 M(+214.2%) | $8.58 M(+28.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $6.68 M(+141.0%) | $952.00 K(-61.3%) | $6.68 M(-0.7%) |
| Sept 2019 | - | $2.46 M(+13.2%) | $6.73 M(+35.6%) |
| June 2019 | - | $2.17 M(+98.2%) | $4.97 M(+49.8%) |
| Mar 2019 | - | $1.10 M(+9.7%) | $3.31 M(+19.5%) |
| Dec 2018 | $2.77 M(-64.5%) | $1.00 M(+43.9%) | $2.77 M(+40.2%) |
| Sept 2018 | - | $695.00 K(+32.9%) | $1.98 M(-53.8%) |
| June 2018 | - | $523.00 K(-5.8%) | $4.28 M(-15.9%) |
| Mar 2018 | - | $555.00 K(+170.7%) | $5.08 M(-34.9%) |
| Dec 2017 | $7.81 M(+159.1%) | $205.00 K(-93.2%) | $7.81 M(-0.3%) |
| Sept 2017 | - | $2.99 M(+125.1%) | $7.84 M(+23.4%) |
| June 2017 | - | $1.33 M(-59.5%) | $6.35 M(+4.7%) |
| Mar 2017 | - | $3.29 M(+1340.8%) | $6.07 M(+101.2%) |
| Dec 2016 | $3.02 M(+161.4%) | $228.00 K(-84.9%) | $3.02 M(+8.2%) |
| Sept 2016 | - | $1.51 M(+44.1%) | $2.79 M(+118.0%) |
| June 2016 | - | $1.05 M(+351.3%) | $1.28 M(+451.3%) |
| Mar 2016 | - | $232.00 K | $232.00 K |
| Dec 2015 | $1.15 M | - | - |
FAQ
- What is CRISPR Therapeutics AG annual capital expenditures?
- What is the all time high annual CAPEX for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG annual CAPEX year-on-year change?
- What is the all time high quarterly CAPEX for CRISPR Therapeutics AG?
- What is the all time high TTM CAPEX for CRISPR Therapeutics AG?
What is CRISPR Therapeutics AG annual capital expenditures?
The current annual CAPEX of CRSP is $11.97 M
What is the all time high annual CAPEX for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high annual capital expenditures is $81.70 M
What is CRISPR Therapeutics AG annual CAPEX year-on-year change?
Over the past year, CRSP annual capital expenditures has changed by -$25.22 M (-67.81%)
What is the all time high quarterly CAPEX for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high quarterly capital expenditures is $37.05 M
What is the all time high TTM CAPEX for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high TTM capital expenditures is $90.03 M